The Pathology of Familial Breast Cancer: Morphological Aspects

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2001 Mar 16

PMID 11250680

Citations 19

Authors

S R Lakhani

Affiliations

Soon will be listed here.

Abstract

A small proportion of breast cancers are due to a heritable predisposition. Recently, two predisposition genes, BRCA1 and BRCA2, have been identified and cloned. The morphological features of tumours from patients harbouring mutations in the BRCA1 and BRCA2 genes differ from each other and from sporadic breast cancers. Both are of higher grade than are sporadic cases. An excess of medullary/atypical medullary carcinoma has been reported in patients with BRCA1 mutations. Multifactorial analysis, however, shows that the only features independently associated with BRCA1 mutations are a high mitotic count, pushing tumour margins and a lymphocytic infiltrate. For BRCA2 mutation, an association with tubular/lobular carcinoma has been suggested, but not substantiated in a larger Breast Cancer Linkage Consortium study. In multifactorial analysis, the independent features were a lack of tubule formation and pushing tumour margins only. The morphological analysis has implications for clinical management of patients.

Citing Articles

Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family.

Sadzeviciene I, Jarmalaite S, Besusparis J, Liaugaudiene O, Asadauskiene J, Brasiuniene B Medicina (Kaunas). 2020; 56(3).

PMID: 32164353 PMC: 7143304. DOI: 10.3390/medicina56030119.

Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System.

Marino M, Riedl C, Bernathova M, Bernhart C, Baltzer P, Helbich T Eur J Radiol. 2018; 106:150-159.

PMID: 30150038 PMC: 7560944. DOI: 10.1016/j.ejrad.2018.07.026.

Rare breast tumors: Review of the literature.

Acevedo C, Amaya C, Lopez-Guerra J Rep Pract Oncol Radiother. 2014; 19(4):267-74.

PMID: 25061520 PMC: 4104018. DOI: 10.1016/j.rpor.2013.08.006.

Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women.

Lee E, McKean-Cowdin R, Ma H, Spicer D, van den Berg D, Bernstein L J Clin Oncol. 2011; 29(33):4373-80.

PMID: 22010008 PMC: 3221522. DOI: 10.1200/JCO.2010.33.6446.

Management of Rare Histological Types of Breast Tumours.

Reimer T Breast Care (Basel). 2010; 3(3):190-196.

PMID: 20824038 PMC: 2931116. DOI: 10.1159/000136826.

References

Lakhani S, Jacquemier J, Sloane J, Gusterson B, Anderson T, van de Vijver M . Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998; 90(15):1138-45. DOI: 10.1093/jnci/90.15.1138. View

Marcus J, Watson P, Page D, Narod S, Lenoir G, Tonin P . Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996; 77(4):697-709. DOI: 10.1002/(sici)1097-0142(19960215)77:4<697::aid-cncr16>3.0.co;2-w. View

Ridolfi R, Rosen P, Port A, Kinne D, Mike V . Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 1977; 40(4):1365-85. DOI: 10.1002/1097-0142(197710)40:4<1365::aid-cncr2820400402>3.0.co;2-n. View

Erdreich L, Asal N, HOGE A . Morphologic types of breast cancer: age, bilaterality, and family history. South Med J. 1980; 73(1):28-32. DOI: 10.1097/00007611-198001000-00012. View

. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet. 1997; 349(9064):1505-10. View

Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C . Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res. 1996; 56(3):471-4. View

Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J . Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559):789-92. DOI: 10.1038/378789a0. View

Agnarsson B, Jonasson J, Bjornsdottir I, Barkardottir R, Egilsson V, Sigurdsson H . Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat. 1998; 47(2):121-7. DOI: 10.1023/a:1005853022804. View

LAGIOS M, Rose M, Margolin F . Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol. 1980; 73(1):25-30. DOI: 10.1093/ajcp/73.1.25. View

10.

Livolsi V, Kelsey J, Fischer D, Holford T, Mostow E, GOLDENBERG I . Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer. 1982; 49(9):1937-40. DOI: 10.1002/1097-0142(19820501)49:9<1937::aid-cncr2820490931>3.0.co;2-h. View

11.

Rosen P, Lesser M, Senie R, Kinne D . Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer. 1982; 50(1):171-9. DOI: 10.1002/1097-0142(19820701)50:1<171::aid-cncr2820500132>3.0.co;2-m. View

12.

Lynch H, Albano W, Heieck J, MULCAHY G, Lynch J, Layton M . Genetics, biomarkers, and control of breast cancer: a review. Cancer Genet Cytogenet. 1984; 13(1):43-92. DOI: 10.1016/0165-4608(84)90087-6. View

13.

Claus E, Risch N, Thompson W, Carter D . Relationship between breast histopathology and family history of breast cancer. Cancer. 1993; 71(1):147-53. DOI: 10.1002/1097-0142(19930101)71:1<147::aid-cncr2820710124>3.0.co;2-v. View

14.

Cannon-Albright L, Thomas A, Goldgar D, Gholami K, Rowe K, Jacobsen M . Familiality of cancer in Utah. Cancer Res. 1994; 54(9):2378-85. View

15.

Miki Y, Swensen J, Futreal P, Harshman K, Tavtigian S, Liu Q . A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182):66-71. DOI: 10.1126/science.7545954. View

16.

Bignon Y, Fonck Y, Chassagne M . Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet. 1995; 346(8969):258. DOI: 10.1016/s0140-6736(95)91310-6. View

17.

Jacquemier J, Eisinger F, Birnbaum D, Sobol H . Histoprognostic grade in BRCA1-associated breast cancer. Lancet. 1995; 345(8963):1503. DOI: 10.1016/s0140-6736(95)91060-3. View

18.

Sloane J, Ellman R, Anderson T, Brown C, Coyne J, Dallimore N . Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology. Eur J Cancer. 1994; 30A(10):1414-9. DOI: 10.1016/0959-8049(94)00261-3. View